Echo Street Capital Management LLC Royalty Pharma PLC Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $541,691 - $647,306	20,628 Added 95.11%	42,317 $1.15 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $271,698 - $335,584	9,179 Added 73.37%	21,689 $666,000
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $438,233 - $526,896	-13,373 Reduced 51.67%	12,510 $450,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $547,009 - $615,018	13,965 Added 117.18%	25,883 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $475,289 - $532,138	11,918 New	11,918 $479,000
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $1.02 Million - $1.2 Million	-27,142 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $1.02 Million - $1.15 Million	27,142 New	27,142 $1.06 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.